Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dhimant Patel
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment
Oncotarget
Oncology
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Development of a Vaccine Targeting Triple-Negative Breast Cancer
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison
Human Pathology
Forensic Medicine
Pathology
Estrogen Receptor-Negative Breast Cancer: New Insights Into Subclassification and Targeting
Clinical Cancer Research
Cancer Research
Oncology
Estrogen Receptor Beta Participate in the Regulation of Metabolizm of Extracellular Matrix in Estrogen Alpha Negative Breast Cancer.
Folia Histochemica et Cytobiologica
Medicine
Forensic Medicine
Pathology
Histology
